Boston Scis Q1 income jumps, while sales dip 3%
finance, graph, business - 86.80 Kb
Boston Scientific has announced an increase in net income, despite a slight dip in sales for the financial results of the 2012 fiscal quarter, which ended March 31, 2012.

On a generally accepted accounting principles (GAAP) basis, the net income for the first quarter of 2012 was $113 million, the Natick, Mass.-based company said.

These results included acquisition- and divestiture-related expenses, restructuring-related charges and amortization expense, of $107 million. On a GAAP basis, the net income for the first quarter of 2011 was $46 million. The reported results included a goodwill impairment charge, acquisition- and divestiture-related net credits, restructuring-related charges, discrete tax items and amortization expense, of $290 million.

Sales for the first quarter of 2012 were $1.87 billion, compared with sales of $1.93 billion for the first quarter of 2011, a decrease of 3 percent, according to Boston Scientific.

For the 2012 first quarter compared with the previous year’s first quarter, its interventional cardiology unit saw a 5 percent decline to $603 million; its cardiac rhythm management business saw the largest drop of 10 percent to $501 million. However, its peripheral interventions and electrophysiology units experienced increase in revenues—8 percent and 1 percent, respectively.

For the drug-eluting stent market, the company said it is maintaining a worldwide share of 34 percent and a U.S. share of 46 percent.

While its international sales remained relatively flat, the U.S. sales for Boston Scientific across all its units dropped 4 percent.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup